Norges Bank
RLAY icon

Norges Bank’s Relay Therapeutics RLAY Stock Holding History

Norges Bank’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-837,417
Closed -$7.08M – 1104
2025
Q4 		$7.08M Buy
+837,417
New +$5.98M ﹤0.01% 1342
2025
Q3 		– Sell
-835,874
Closed -$2.89M – 1226
2025
Q2 		$2.89M Sell
835,874
-3,799,263
-82% -$11.3M ﹤0.01% 1384
2025
Q1 		$12.1M Sell
4,635,137
-1,146,741
-20% -$4.49M ﹤0.01% 1258
2024
Q4 		$23.8M Sell
5,781,878
-135,637
-2% -$738K ﹤0.01% 1202
2024
Q3 		$41.9M Buy
5,917,515
+2,598,173
+78% +$19.4M 0.01% 1034
2024
Q2 		$21.6M Sell
3,319,342
-73,283
-2% -$501K ﹤0.01% 1199
2024
Q1 		$28.2M Buy
3,392,625
+323,652
+11% +$3.16M ﹤0.01% 1167
2023
Q4 		$33.8M Buy
3,068,973
+1,562,145
+104% +$13.2M 0.01% 1087
2023
Q3 		$12.7M Sell
1,506,828
-106,956
-7% -$1.15M ﹤0.01% 1383
2023
Q2 		$20.3M Hold
1,613,784
– – ﹤0.01% 1250
2023
Q1 		$26.6M Sell
1,613,784
-174,539
-10% -$3.13M 0.01% 1137
2022
Q4 		$26.7M Buy
1,788,323
+57,636
+3% +$1.1M 0.01% 1130
2022
Q3 		$38.7M Buy
1,730,687
+313,499
+22% +$6.88M 0.01% 880
2022
Q2 		$23.7M Buy
1,417,188
+479,262
+51% +$10.3M 0.01% 1159
2022
Q1 		$28.1M Buy
937,926
+117,926
+14% +$2.86M 0.01% 1206
2021
Q4 		$25.2M Buy
820,000
+322,235
+65% +$10.2M 0.01% 1347
2021
Q3 		$15.7M Buy
497,765
+267,135
+116% +$8.99M ﹤0.01% 1609
2021
Q2 		$8.44M Buy
230,630
+24,234
+12% +$799K ﹤0.01% 1816
2021
Q1 		$7.13M Sell
206,396
-2,689
-1% -$117K ﹤0.01% 1864
2020
Q4 		$8.69M Buy
+209,085
New +$9.45M ﹤0.01% 1792

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Norges Bank's RLAY Position: Q1 2026 in Review

Norges Bank sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 837,417 shares — an estimated $7.08M sold.

Norges Bank first reported a position in RLAY in Q4 2020 and held it in 20 quarters. The position peaked at $41.9M in Q3 2024. 244 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Norges Bank reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 837,417 Relay Therapeutics shares in Q1 2026, an estimated $7.08M.
  • Norges Bank first reported a position in Relay Therapeutics in Q4 2020 and held it in 20 quarters.
  • Norges Bank's Relay Therapeutics position peaked at $41.9M in Q3 2024.
  • 244 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.